These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15345480)

  • 41. Myocardial Strain in Prediction of Outcomes After Surgery for Severe Mitral Regurgitation.
    Kim HM; Cho GY; Hwang IC; Choi HM; Park JB; Yoon YE; Kim HK
    JACC Cardiovasc Imaging; 2018 Sep; 11(9):1235-1244. PubMed ID: 29778855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In-vivo antioxidant and anti-inflammatory activity of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists in animal model of bronchial asthma.
    El-Naa MM; El-Refaei MF; Nasif WA; Abduljawad SH; El-Brairy AI; El-Readi MZ
    J Pharm Pharmacol; 2015 Oct; 67(10):1421-30. PubMed ID: 26099551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beta1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation.
    Tallaj J; Wei CC; Hankes GH; Holland M; Rynders P; Dillon AR; Ardell JL; Armour JA; Lucchesi PA; Dell'Italia LJ
    Circulation; 2003 Jul; 108(2):225-30. PubMed ID: 12847066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intervention of rosiglitazone on myocardium Glut-4 mRNA expression during ischemia-reperfusion injury in cardio-pulmonary bypass in dogs.
    Liu B; Liang G; Xu G; Liu D; Cai Q; Gao Z
    Mol Cell Biochem; 2013 Jan; 373(1-2):279-84. PubMed ID: 23111893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
    Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Afterload reduction may halt and beta-adrenergic blockade may worsen progression of left ventricular dysfunction in patients with chronic compensated mitral regurgitation: a retrospective cohort study.
    Oh SH; Meyers DG
    Angiology; 2007; 58(2):196-202. PubMed ID: 17495269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of tissue Doppler echocardiography in early detection of left ventricular systolic dysfunction in patients with mitral regurgitation.
    Nazli C; Kinay O; Ergene O; Yavuz T; Gedikli O; Hoscan Y; Ozaydin M; Altinbas A; Dogan A; Kahraman H; Acar G
    Int J Cardiovasc Imaging; 2003 Jun; 19(3):199-209. PubMed ID: 12834156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty.
    Maniu CV; Patel JB; Reuter DG; Meyer DM; Edwards WD; Rihal CS; Redfield MM
    J Am Coll Cardiol; 2004 Oct; 44(8):1652-61. PubMed ID: 15489099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Left ventricular function quantified by myocardial strain imaging in small-breed dogs with chronic mitral regurgitation.
    Smith DN; Bonagura JD; Culwell NM; Schober KE
    J Vet Cardiol; 2012 Mar; 14(1):231-42. PubMed ID: 22361170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disparity between ejection and end-systolic indexes of left ventricular contractility in mitral regurgitation.
    Berko B; Gaasch WH; Tanigawa N; Smith D; Craige E
    Circulation; 1987 Jun; 75(6):1310-9. PubMed ID: 3568333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta1-adrenoceptor blockade mitigates excessive norepinephrine release into cardiac interstitium in mitral regurgitation in dog.
    Hankes GH; Ardell JL; Tallaj J; Wei CC; Aban I; Holland M; Rynders P; Dillon R; Cardinal R; Hoover DB; Armour JA; Husain A; Dell'Italia LJ
    Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H147-51. PubMed ID: 16772522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation between myocardial beta-adrenergic receptor and left ventricular function in patients with left ventricular volume overload due to chronic mitral regurgitation with or without aortic regurgitation.
    Sakagoshi N; Nakano S; Taniguchi K; Hirata N; Matsuda H
    Am J Cardiol; 1991 Jul; 68(1):81-4. PubMed ID: 1647656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of incipient left ventricular dysfunction in patients with chronic primary mitral regurgitation: a velocity vector imaging study.
    Moustafa SE; Kansal M; Alharthi M; Deng Y; Chandrasekaran K; Mookadam F
    Eur J Echocardiogr; 2011 Apr; 12(4):291-8. PubMed ID: 21343164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation.
    Dell'Italia LJ; Meng QC; Balcells E; Straeter-Knowlen IM; Hankes GH; Dillon R; Cartee RE; Orr R; Bishop SP; Oparil S
    Am J Physiol; 1995 Dec; 269(6 Pt 2):H2065-73. PubMed ID: 8594918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronary blood flow in dogs with contractile dysfunction due to experimental volume overload.
    Carabello BA; Nakano K; Ishihara K; Kanazawa S; Biederman RW; Spann JF
    Circulation; 1991 Mar; 83(3):1063-75. PubMed ID: 1825623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting the sympatho-adrenergic link in chronic rheumatic mitral regurgitation: assessing the role of oral beta-blockers.
    Sahoo D; Kapoor A; Sinha A; Khanna R; Kumar S; Garg N; Tewari S; Goel P
    Cardiovasc Ther; 2016 Aug; 34(4):261-7. PubMed ID: 27219616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells.
    Zhang CH; Wen ZQ; Li JF; Li CZ; Shi M; Yang GW; Lan SM; Zhu Y; Wang F; Zhang YJ; Wang YY; Zhang H
    Chin Med J (Engl); 2008 Jan; 121(2):166-71. PubMed ID: 18272045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three-dimensional changes in left and right ventricular geometry in chronic mitral regurgitation.
    Young AA; Orr R; Smaill BH; Dell'Italia LJ
    Am J Physiol; 1996 Dec; 271(6 Pt 2):H2689-700. PubMed ID: 8997332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C
    Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.